Multisystem Inflammatory Syndrome in Children.
J Emerg Med
; 62(1): 28-37, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2180429
ABSTRACT
BACKGROUND:
Multisystem inflammatory syndrome in children (MIS-C) is a newly recognized condition affecting children with recent infection or exposure to coronavirus disease 2019 (COVID-19). MIS-C has symptoms that affect multiple organs systems, with some clinical features resembling Kawasaki disease (KD) and toxic shock syndrome (TSS). OBJECTIVE OF THE REVIEW Our goal was to review the current literature and describe the evaluation and treatment algorithms for children suspected of having MIS-C who present to the emergency department.DISCUSSION:
MIS-C has a wide clinical spectrum and diagnosis is based on a combination of both clinical and laboratory findings. The exact mechanism of immune dysregulation of MIS-C is not well understood. Physical findings may evolve and do not necessarily appear at the same time. Gastrointestinal, cardiac, inflammatory, and coagulopathy manifestations and dysfunction are seen frequently in MIS-C.CONCLUSIONS:
The diagnosis of MIS-C is based on clinical presentation and specific laboratory findings. In the emergency setting, a high level of suspicion for MIS-C is required in patients exposed to COVID-19. Early diagnosis and prompt initiation of therapy offer the best chance for optimal outcomes.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
/
Síndrome Mucocutáneo Linfonodular
Tipo de estudio:
Estudios diagnósticos
/
Estudio experimental
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Niño
/
Humanos
Idioma:
Inglés
Revista:
J Emerg Med
Asunto de la revista:
Medicina de Urgencia
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS